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Objective: To examine the 10-year risk of stroke among patients with acute urinary retention (AUR) in
Taiwan, using a population-based dataset.
Methods: This retrospective cohort study included 38,433 patients aged > 50 years with AUR, with or
without catheterization, and 38,433 matched patients without AUR (controls) sourced from the Longi-
tudinal Health Insurance Database from 2001 to 2010. Cox proportional hazards regression was used to
evaluate the association between AUR and the risk of stroke during the subsequent 10-year follow-up
period, after adjusting for sociodemographic characteristics, hypertension, diabetes, hyperlipidemia,
coronary heart disease, and urinary tract infection.
Results: Of the 38,433 patients with AUR, 2805 (7.3%) had strokes during the follow-up period compared
with 1077 (2.8%) controls (crude hazard ratio, 2.69; 95% conﬁdence interval, 2.5e2.88). After adjusting
for potential confounders, risk of stroke was increased in patients with AUR (hazard ratio, 2.36; 95%
conﬁdence interval, 2.19e2.53). There was a signiﬁcant difference in the 10-year stroke-free survival rate
between the patients with and without AUR (p < 0.001, log-rank test). In total, 26.77% of the patients
with AUR who experienced a stroke during the 10-year follow-up period had ischemic stroke, while
others had hemorrhagic stroke.
Conclusion: There was signiﬁcant difference in the risk of stroke between patients with and without AUR.
Preventive measures should be taken for patients with AUR, which may be associated with an increased
risk of subsequent stroke. Large-scale population-based studies in other countries and regions are
recommended.
Copyright © 2016, Taiwan Urological Association. Published by Elsevier Taiwan LLC. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Acute urinary retention (AUR) is a severe problem characterized
by a sudden inability to pass urine and is associated with lower
abdominal pain.1 It is found among all age groups2 and is a major
public health issue.
In a worldwide survey on men with benign prostate hyperpla-
sia,3 AUR was subcategorized as spontaneous and precipitated.
Spontaneous AURwas deﬁned as AUR associated with aging, severement of Surgery, Chang Gung
u-Z City, Chiayi Hsien 613,
o).
ociation. Published by Elsevier Talower urinary tract symptoms, low peak ﬂow rate, and high post-
void residual urine.4,5 Precipitated AUR was deﬁned as retention
associated with a surgical procedure with general, local, or regional
anesthesia, bladder over-distension, urinary tract infection, or
medication with anticholinergics or sympathomimetic effects.6
These two types of AUR are different in prognosis. Precipitated
AUR is associated with a much higher 1-year mortality rate (24-fold
increase compared with the general population) than spontaneous
AUR (10-fold increase).7 Patients with precipitated AUR often have
a higher prevalence of severe underlying comorbid conditions. The
reason for the increased mortality rates in both types of AUR is not
well understood, although it may be associated with pathophysi-
ological changes that result in or result from AUR.
Acute bladder distension in AUR has been observed to evoke
hypertension in clinical patients.8 Hypertension is associated withiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
C.-S. Chen et al. / Urological Science 27 (2016) 71e7572stroke, and its control has been shown to decrease the long-term
rates of incident and recurrent hemorrhagic and ischemic stroke.9
Sympathetic activity increase is often associated with AUR,10 and
presents as hypertension, tachycardia, and anxiety. In extreme
cases of sympathetic activation such as in autonomic dysreﬂexia in
patients with incomplete spinal cord injury, stroke has been re-
ported when AUR triggers autonomic dysreﬂexia.11
Using a population-based database, the present study aimed to
examine the 10-year risk of stroke among patients with or without
AUR. To the best of our knowledge, the present study is the ﬁrst to
estimate the risk of stroke among patients with previous episodes
of AUR.
2. Materials and methods
2.1. Database
The present study used data sourced from the Longitudinal
Health Insurance Database (LHID) 2010. The LHID 2010 contains
original medical claims data and registry ﬁles for 1 million in-
dividuals randomly sampled from all enrollees in the Taiwan Na-
tional Health Insurance (NHI) program in 2010 (n ¼ 23.16 million).
This database is compiled by the Taiwan National Health Research
Institute, which also validated that there is no signiﬁcant difference
in sex distribution between the patients in the LHID 2010 and all
enrollees under the NHI program. The LHID 2010 is provided to
scientists in Taiwan for research purposes, and many researchers
have used this dataset for their studies. The present study was
exempt from full review by the Institutional Review Board because
the LHID 2010 consists of deidentiﬁed secondary data released to
the public for research purposes.
2.2. Study population
We selected all patients who visited ambulatory care centers or
were admitted to hospital with a principal diagnosis of AUR (The
International Classiﬁcation of Diseases, 9th Revision, Clinical
Modiﬁcation, ICD-9-CM, code 788.2, retention of urine) or received
catheterization (transurethral or suprapubic) procedures from the
LHID 2010 from 1 January 1997 to 31 December 2010 (n ¼ 167,871).
We excluded patients who had been diagnosed with AUR or
undergone urine catheterization during ambulatory care visits or
hospitalizations before 2001, with the aim of only including new-
onset cases (n ¼ 112,423). We also excluded those aged <
50 years to focus more on the group at risk of stroke (n ¼ 70,057).
Finally, we excluded patients who had been diagnosed with any
type of stroke (ICD-9-CM codes 430e438) before 2001 (n ¼ 3933).
However, as the Taiwan NHI program was initiated in 1995, we
could only trace the use of medical services from 1996 to 2010.
Therefore, we could not rule out the possibility that some patients
had been diagnosedwith stroke or AUR before 1996. In total, 38,433
patients with AUR were included as the case group.
The comparison cohort included individuals in the registry of
beneﬁciaries of the LHID 2010 that were matched to the study
cohort (n ¼ 832,129). We ﬁrst excluded patients who withdrew
before 2010 (n ¼ 32,325). We randomly extracted 38,433 in-
dividuals (1 for every patient with AUR) matched in terms of age
difference < 1 year and the year of index date. We deﬁned the ﬁrst
ambulatory care visit for urine catheterization as the index date for
the patients who had ambulatory visits. For patients who were
admitted, the date of urine catheterizationwas deﬁned as the index
date. We also checked that no selected individual had ever received
a diagnosis of AUR prior to their index ambulatory care visit.
Furthermore, we also ensured that none of the selected comparison
individuals had ever been diagnosed with AUR since 1996.The patients were individually tracked until December 31, 2010
to identify those who had had strokes (ICD-9-CM codes 434.91 or
431), starting from their index date.
2.3. Statistical analysis
Pearson's Chi-square test was used to examine differences be-
tween patients with or without AUR diagnosis, in terms of socio-
demographic characteristics (age; monthly income; and the
geographical location of the patient's residence: northern, central,
eastern, or southern Taiwan) and select comorbid medical disor-
ders that are considered risk factors for stroke and AUR. These
comorbid disorders included hypertension (ICD-9-CM codes
401e405), diabetes (ICD-9-CM code 250), hyperlipidemia (ICD-9-
CM codes 272.0e272.4), coronary heart disease (ICD-9-CM codes
410e414), and urinary tract infection (ICD-9-CM code 599 or
V13.02). These conditions were counted only when they occurred
before the date of the stroke, and the interval between the ﬁrst and
last claims was > 1 year. In addition, they were only counted if they
occurred either during hospitalization or during ambulatory care
visits, and with claim codes for at least 1 year. We also computed
the 10-year stroke-free survival rate using the Product-Limit Sur-
vival Estimates (SAS, PROC LIFETIME, equivalent to KaplaneMeier
method), and used the log-rank test to compare differences in the
risk of stroke for patients with or without AUR. In addition, we used
Cox proportional hazards regression to evaluate the association
between AUR and the risk of stroke during the study period, after
adjusting for sociodemographic characteristics and select comorbid
medical disorders. A p-value < 0.05 (2-sided) was considered to be
statistically signiﬁcant. SAS statistical package (SAS System for
Windows, Version 9.2; SAS Institute Inc., Cary, NC, USA) was used to
perform all statistical analyses.
2.4. Ethics
Our study was approved by the Chang Gung Memorial Hospital
Institutional Review Board, and the original LHID 2010 was dei-
dentiﬁed by the National Health Research Institute in Taiwan.
3. Results
Table 1 shows the distribution of demographic characteristics
and comorbid medical disorders for the sampled patients, stratiﬁed
by whether or not they had AUR. There were signiﬁcant differences
in the distribution of comorbidities, including hypertension (61.21%
vs. 50.72%; p < 0.0001), diabetes (29.79% vs. 20.61%; p < 0.0001),
hyperlipidemia (16.9% vs. 15.08%; p < 0.0001), coronary heart dis-
ease (8.8% vs. 5.08%; p< 0.0001), and urinary tract infection (26.48%
vs. 12.04; p < 0.0001) between patients with and without AUR.
There were no signiﬁcant differences in the mean age (66.87 years
vs. 66.94 years; p ¼ 0.411), monthly income, and urban or rural
residency of the patients.
Table 2 shows the percentage of stroke during the 10-year
follow-up period among patients with and without AUR. In the
total sample of 76,866 patients with or without AUR, 3882 (5.05%)
patients had strokes during the 10-year follow-up period. These
included 2805 patients with AUR (7.3% of all patients who had AUR)
and 1077 patients who did not have AUR (2.8% of all patients who
did not have AUR). There was a signiﬁcant difference in the 10-year
stroke-free survival rate between the patients with and without
AUR (p < 0.001, log-rank test). The results of product-limit survival
estimates (survival analysis) are shown in Figure 1.
Table 2 also presents the crude and adjusted hazard ratios (HR)
for stroke comparing patients with or without AUR. After censoring
cases who died from nonstroke related causes during the 10-year
Table 1
Demographic characteristics and comorbid medical conditions of the patients with
acute urinary retention (AUR) matched one-to-one with patients without AUR at
same index date, 2001e2010 (n ¼ 38,433).
Variable With AUR Without AUR p
n ¼ 38433 n ¼ 38433
Total No. % Total No. %
Sex > 0.999
Female 19,653 51.14 19,653 51.14
Male 18,780 48.86 18,780 48.86
Age group (y) 0.9975
50e59 12,141 31.59 12,141 31.59
60e69 10,948 28.49 10,956 28.51
70+ 15,344 39.92 15,336 39.9
Residence 1.00
Urban 25,968 67.57 25,968 67.57
Rural 12,465 32.43 12,465 32.43
Monthly income 1.00
Fixed premium and dependent 21,343 55.53 21,343 55.53
< 20,000 NTD 1060 2.76 1060 2.76
20,000e39,999 NTD 13,992 36.41 13,992 36.41
 40,000 NTD 2038 5.3 2038 5.3
Geographic region < 0.0001
Northern 16,357 42.56 17,854 46.45
Central 10,326 26.87 8024 20.88
Southern 10,048 26.14 11,105 28.89
Eastern 1702 4.43 1450 3.77
Comorbidity
Hypertension 23,523 61.21 19,495 50.72 < 0.0001
Diabetes 11,449 29.79 7920 20.61 < 0.0001
Hyperlipidemia 6494 16.9 5794 15.08 < 0.0001
Coronary heart disease 3384 8.8 1951 5.08 < 0.0001
Urinary tract infection 10,177 26.48 4626 12.04 < 0.0001
Stroke < 0.0001
No 35,628 92.7 37,356 97.2
Yes 2805 7.3 1077 2.8
NTD¼New Taiwan Dollars.
Table 2
Crude and adjusted hazard ratios for stroke among the sampled patients during the
10-year follow up starting from index ambulatory care visit.
Total With AUR Without AUR
n ¼ 76,866 n ¼ 38,433 n ¼ 38,433




No 72,984 94.95 35,628 92.7 37,356 97.2
Yes 3882 5.05 2805 7.3 1077 2.8
Crude HR (95% CI) 2.69 (2.5e2.88)
Adjusted HR (95% CI) 2.36 (2.19e2.53)
AUR ¼ acute urinary retention; CI ¼ conﬁdence interval; HR ¼ hazards ratio.
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the HR of stroke for patients with AUR during the 10-year follow-up
period was 2.69 [95% conﬁdence interval (CI), 2.5e2.88; p < 0.0001]
compared with patients without AUR. Similarly, a signiﬁcant dif-
ference in the risk of stroke between patients with or without AUR
was found after adjusting for age, monthly income, and the
geographical location of residence, as well as hypertension, dia-
betes, coronary heart disease, heart failure, atrial ﬁbrillation, and
hyperlipidemia (HR, 2.36; 95% CI, 2.19e2.53).
We further analyzed the types of stroke among the patients with
or without AUR. In total, 26.77% of the patients with AUR who
experienced a stroke during the 10-year follow-up period had an
ischemic stroke. There was signiﬁcant difference in the type of
stroke between the two groups (p < 0.0001; Table 3).
4. Discussion
The present study reports epidemiological data regarding the
10-year risk of stroke among patients with or without AUR. This is
the ﬁrst population-based report of its kind on an Asian popula-
tion. The results showed that there was a signiﬁcantly increased
risk of ischemic or hemorrhagic stroke for patients aged > 50 years
with AUR compared with those without AUR, after adjusting for
age, monthly income, and geographical location of residence, as
well as comorbid hypertension, diabetes, hyperlipidemia, coronary
heart disease, and urinary tract infection (adjusted HR, 2.36; 95%
CI, 2.19e2.53). The present study is a more speciﬁc investigation
compared with that of Armitage et al,7 who reported that mor-
tality in men admitted to hospital with acute urinary retentionwas
high and signiﬁcantly increased with age and comorbidities inNational Health Service hospitals in England. Although the causes
of mortality were not speciﬁed in the previous study, our analysis
showed that stroke was a major morbidity following episodes of
AUR.
In most previous studies, new-onset AURwas only referred to as
one of the major patient care problems accompanying stroke,
instead of a risk factor for stroke. AUR may interfere with patient
discharge and complicate patient rehabilitation.12 Stroke patients
are generally more vulnerable to developing urinary retention, and
it has been reported that around one-third of stroke patients may
have urinary retention during rehabilitation.13 Urinary retention
was signiﬁcantly associated with cognitive impairment, diabetes
mellitus, aphasia, lower functional status, and urinary tract infec-
tion. These studies reported that AUR occurs after a stroke, but few
focused on whether AUR may lead to stroke. The value of our
analysis is in the conﬁrmation that patients who develop AUR may
be at a higher risk of having a stroke.
This risk of stroke is associated with poor control of hyperten-
sion.14 A previous study indicated that resistant hypertension can
signiﬁcantly increase the risk of nonfatal stroke.15 Another recent
study suggested that chronic bladder distension can induce severe
hypertensive spells and result in neurological deﬁcits.16 Hyper-
tension related to chronic urinary tract obstruction has been re-
ported to be the most common form of surgically correctable renal
hypertension,17 and is probably associated with malfunction of the
sympathetic nervous system.18 Bladder distention may affect kid-
ney and liver function through sympathetic activation. In an animal
model, AUR was found to activate sympatheticedependent ves-
icovascular reﬂex, which caused vasoconstriction and hypoxia, and
evoked proinﬂammatory and proapoptotic oxidative injury in rat
livers.18 AUR has also been found to enhance renal sympathetic
activity leading to renal vasoconstriction and an increase in
oxidative stress in rat kidneys.19 The vasoconstriction responses
induced by AUR can be dramatic. AUR is associated with sympa-
thetic activation, which may result in vasoconstriction and ﬂuctu-
ation of blood pressure. When AUR occurs in patients with spinal
cord injury, hemorrhagic stroke has been reported.11 Autonomic
dysreﬂexia refers to spinal cord injury patients with injuries above
the sixth thoracic vertebra, who may suffer from sudden severe
hypertension triggered by AUR.20 Blood pressure in these in-
dividuals may rise to dangerous levels and, if not treated, can lead
to stroke and possibly death.21 AUR has been reported to be the
most common triggering factor for autonomic dysreﬂexia and
bladder distension in men.11
Among the 3882 cases with AUR in this study, only nine had
previously been diagnosed with spinal cord injuries. Therefore
autonomic dysreﬂexia-related hypertension crisis may not explain
the increased risk of stroke in the AUR patients. Only a few articles
have focused on sympathetic activity and stroke, even though it is
generally believed that sympathetic innervation is important in
Figure 1. Product-limit survival estimates demonstrating survival differences in the 10-year stroke-free survival rate between the patients with and without acute urinary retention
(AUR).
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sibilities. First, patients without spinal cord injuries may still have
poorly regulated sympathetic activity, which can be excessively
activated after being triggered by AUR. Second, AURmay repeatedly
irritate patients' sympathetic system and eventually result in
stroke. Further clinical studies are needed to investigate these
possible mechanisms.
The strength of the present study is the use of a representative
sample from a comprehensive national database. In addition, the
dataset used in the current study allowed for the follow up of all
medical services used by the sampled patients. However, there are
some limitations to this study. First, information regarding certain
characteristics of the patients with AUR that may contribute to
stroke, such as alcohol intake, smoking, dietary habits, nutritional
status, and body mass index were not available in the database. In
addition, it may be difﬁcult to generalize these ﬁndings to western
countries because of differences in diet, lifestyle, and smoking
prevalence.
It is worth noting that in selected AUR patients, there is a slightly
higher percentage of female AUR. This may be confusing because
most patients who needed catheterization in outpatient clinics
were male. However, because sex was matched, this does not affect
the comparison of stroke risks. The AUR discussed in this article is
ﬁrst-ever AUR, which may be considered as incidence. Clinically,
there are more men with AUR, who needed catheterization. This
observation is based on number of men being catheterized.Table 3
Comparison of stroke type between the patients with and without acute urinary
retention (AUR).
Type AUR Comparison p
n % n %
Ischemic 751 26.77 139 12.91 < 0.0001
Hemorrhagic 2054 73.23 938 87.09 < 0.0001However, they may have repeat AUR instead of ﬁrst-ever AUR. This
will result in the impression that AUR is more common in men.
This study emphasized the importance in early prevention of
ﬁrst AUR. After AUR, there may be standard protocols for treating
voiding problem. All patients discussed here had National Health
Insurance, which has strict peer review mechanisms for clinical
misbehavior. Therefore, we are conﬁdent that majority of patients
were treated with similar clinical standards. This study did not
focus on speciﬁc AUR that can be managed with surgery. Speciﬁc
types of AURmay beneﬁt from certain types of treatment. Generally
speaking, however, once ﬁrst-ever AUR occurs, a change in ho-
meostasis may gradually lead to certain consequences. It can only
be prevented with awareness of this trend along with good clinical
practices.
Finally, the present study found that patients with AUR had an
increased risk of developing either hemorrhagic stroke or
ischemic stroke. Although it may be assumed that hemorrhagic
stroke may prevail, the ratio of ischemic stroke actually increased
in ﬁrst-ever AUR patients. Autonomic functions have been found to
have important therapeutic implications in acute ischemic as well
as in hemorrhagic stroke.16 It is possible that factors resulting in
AUR may be related more with vessel spasm or occlusion. There-
fore, ratio of ischemic stroke over hemorrhagic type is slightly
higher in the AUR group compared with control group. Since AUR
is related to autonomic dysfunction, it is reasonable that the
incidence rates of both ischemic stroke and hemorrhagic stroke
were increased.
5. Conclusion
In the present study, we found that there was a signiﬁcant dif-
ference in the risk of stroke between ethnic Chinese patients with
and without AUR, even after adjusting for potential confounders
and known risk factors for cerebrovascular disease. The ﬁndings
suggest that preventive measures should be taken for patients with
C.-S. Chen et al. / Urological Science 27 (2016) 71e75 75AUR, which is currently not associated with an increased risk of
subsequent stroke, and provide useful information for physicians
weighing the beneﬁts of AUR treatment. Further large-scale pop-
ulation-based studies in other countries and regions are recom-
mended to conﬁrm the ﬁndings of the present study.
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